Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling
Cancer Letters · 2025-02 · 611 · 217426
DOI: 10.1016/j.canlet.2024.217426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025-02. Verfasst von Wenfei Du und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 2002…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Histones, Lipid Metabolism. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Lipid metabolism reprogramming is critical for the initiation and progression of hepatocellular carcinoma (HCC). However, how the dysregulation of lipid metabolism contributes to HCC development remains largely unknown. Here, we report that the m6A reader YTHDC1-mediated epigenetic regulation of the long noncoding RNA NEAT1 activates stearoyl-CoA desaturase (SCD)-associated lipid metabolic processes during HCC progression. Mechanistically, histone lactylation in HCC induces increased expression of YTHDC1, increasing the stability of m6A-modified NEAT1. The histone acetyltransferase p300 is then recruited by NEAT1 and activates SCD by increasing the level of histone acetylation at the SCD promoter, thus facilitating HCC progression via hepatocellular lipid metabolism remodeling. Taken together, these discoveries suggest a close link between the epigenetic machinery and lipid metabolic abnormalities, which promotes cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200240, China.
- Department of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, Anhui, 230032, China.
- Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.
- Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
- Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China. Electronic address: fanyingsh@126.com.
- Shanghai Center for Systems Biomedicine, Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200240, China. Electronic address: xiaodongzhao@sjtu.edu.cn.
Zitieren
APA
Du, W., Tan, S., Peng, Y., Lin, S., Wu, Y., Ding, K., Chen, C., Liu, R., Cao, Y., Li, Z., Gu, S., Feng, H., Wan, B., Tao, S. C., Wang, N., Fan, Y., & Zhao, X. (2025). Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling. Cancer Letters, 611, 217426. https://doi.org/10.1016/j.canlet.2024.217426
Vancouver
Du W, Tan S, Peng Y, Lin S, Wu Y, Ding K, et al. Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling. Cancer Letters. 2025;611:217426. doi:10.1016/j.canlet.2024.217426
BibTeX
@article{Du2025,
author = {Du, Wenfei and Tan, Sheng and Peng, Yonglin and Lin, Sang and Wu, Yunqiang and Ding, Keshuo and Chen, Changyu and Liu, Ruiqi and Cao, Yu and Li, Zheyi and Gu, Sijie and Feng, Haoran and Wan, Bingbing and Tao, Sheng-Ce and Wang, Niansong and Fan, Ying and Zhao, Xiaodong},
title = {Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling},
journal = {Cancer Letters},
year = {2025},
volume = {611},
pages = {217426},
doi = {10.1016/j.canlet.2024.217426}
}
EUVIMED